Trump's remarks came a day before the Fed was set to announce its next decision on interest rates.Politicsread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
China is reducing support for its electric carmakers a move experts and industry insiders warn could lead to consolidation and waning investor appetite. But some of the...Technologyread more
Is your CEO on the list? Glassdoor has the results.Power Playersread more
Joseph Gaspar, the chief financial officer at Elbit Systems, said M&A among firms in the sector began to pick up pace in the 1980s and looks set to continue.Paris Air Showread more
Stocks in Asia rose in Wednesday afternoon trade following positive developments overnight on the U.S.-China trade front.Asia Marketsread more
Signs of companies moving out of Hong Kong have emerged, members of the business community told CNBC following massive protests in the city. But one analyst said Hong Kong's...China Politicsread more
Sen. Josh Hawley, a well-known tech critic, introduced legislation on Wednesday that would remove the immunity big technology companies receive for user-posted content under...Technologyread more
In its new "Future Skills" report, LinkedIn has identified what it calls the 10 "rising skills" of the future and the jobs associated with them.Get Aheadread more
Democratic Rep. Maxine Waters on Tuesday requested that Facebook pause its development of Libra, an upcoming cryptocurrency that the company plans to release in 2020.Technologyread more
Has your CEO won over enough workers in Germany to make the cut? Glassdoor reveals.Power Playersread more
Health-care companies saw their stocks shoot through the roof on Wednesday after Republican Donald Trump's shocking White House victory.
Shares of Dow component Pfizer and Mylan rose 7 percent and 4.8 percent Wednesday, respectively. Allergan and Amgen shares followed, gaining more than 8 percent and 5 percent, respectively. The iShares Nasdaq Biotechnology ETF (IBB) skyrocketed, gaining nearly 9 percent on the day, crossing its 50-day moving average level of 278.20 for the first time since early October.
The biotechnology sector has been under pressure over the past year as investors feared a victory from Democratic nominee Hillary Clinton would bring about drug-pricing pressures.
In a Wednesday note, Deutsche Bank analysts said health-care stocks are "likely to rally most near-term," adding they see upside of at least 20 percent within the sector.
Trump shocked the world by beating Clinton in the race for the White House. Trump's success was only part of a larger, crushing victory for the Republican Party, which retained the House and appeared poised to maintain Senate control.